Nirsevimab Library
Resource Utilization and Cost in Management of Febrile Infants After the 2021 Clinical Guideline
This article is about a study on how resources and costs are used to care for infants with fevers after new guidelines were introduced in …
Changes in the Management of Children with Brief Resolved Unexplained Events (BRUEs)
This article discusses changes in managing children with brief resolved unexplained events (BRUE), focusing on reduced hospitalization rates and the importance of clinical evaluation and …
Adult Tourniquet for Use in School-Age Emergencies
2019
· Nemours Children's Health
This article explains how adult Combat Application Tourniquets (CAT) can be used effectively on children aged 6 to 16 years. It describes a study that …
Age, Adverse Childhood Experiences, and Healthcare Utilization
This article with video abstract is about a study that looks at how age and bad experiences in childhood affect the use of healthcare. It …
Fine Particles in Wildfire Smoke and Pediatric Respiratory Health in California
This article is about how wildfire smoke affects children's breathing in California. It describes that fine particles from wildfires, known as PM2.5, are much more …
Immunization for Respiratory Syncytial Virus-Promises and Pitfalls
This editorial discusses the potential benefits and challenges of vaccines for the respiratory syncytial virus (RSV). It explains how RSV affects children and older adults, …
Pricey or Priceless: Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention in Infants
2024
· University of Antwerp
This comment discusses the cost-effectiveness of preventing RSV in infants. It compares different strategies, like using monoclonal antibodies (nirsevimab) and a maternal vaccine (MV). It …
Introduction to This JPIDS Supplement: All Infant Protection Against Serious RSV Disease
This article describes the challenges and advancements in protecting infants from serious RSV disease. It highlights the unpredictability of RSV, especially during the COVID-19 pandemic, …
Single-Dose Nirsevimab Prevents RSV Infection
This article commentary discusses a study on nirsevimab, a single-dose treatment that helps prevent RSV infections in preterm infants. Conducted across 164 sites in 23 …
Parent Perspectives on Nirsevimab for Their Newborn
2024
· Yale School of Medicine,
· Yale University
This article explores how parents feel about using nirsevimab for their newborns. Nirsevimab is a medicine that helps protect babies from RSV, a common virus …